May is Brain Tumor Awareness Month! Share your voice and raise brain tumor awareness: Download our free toolkit and spread the word.
ABTA PARTNERS WITH NATIONAL CANCER INSTITUTE TO ACCELERATE RARE BRAIN TUMOR RESEARCH Brain and central nervous system (CNS) tumor diagnoses only represent 1.4 percent of all cancers, making it challenging
The American Brain Tumor Association (ABTA) is partnering with the National Cancer Institute’s NCI-CONNECT program to advance the understanding of rare adult central nervous system (CNS) cancers to improve approaches
Travel was always a part of Sharon Mercer’s life ever since she was kid. She grew up as a military brat and lived in several bases in the U.S. and
In honor of Brain Tumor Awareness Month, we are hosting a Q&A session on our online support community, Connections. Dr. Stefania Maraka and Jean Arzbaecher, RN, MS, will be available
ABTA PARTNERS WITH THE FDA AND BRAIN TUMOR COMMUNITY TO EVALUATE AND ADVANCE CLINICAL DEVELOPMENT OF BRAIN METASTASES TREATMENTS Approximately 200,000 cancer patients are diagnosed with brain metastases every year.
The American Association for Cancer Research (AACR) held its 2019 Annual Meeting, March 29 – April 3, 2019 in Atlanta. The AACR Annual Meeting provides an opportunity for the cancer
Registration is now open for American Brain Tumor Association 2019 National Conference. Are you ready to harness the benefits of cutting-edge information at the ABTA 2019 National Conference, September
With its Metastatic Brain Tumor Initiative, the American Brain Tumor Association (ABTA) is taking the lead to ensure patients diagnosed with brain metastases are represented in clinical trials and have
Meet Paul McDowell of Cleveland, Ohio. It has been 23 years since his last treatment for two brain tumors, including a glioblastoma (GBM). While Paul can’t explain his survival from
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
